{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:29:51Z","timestamp":1772213391188,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.amjmed.2012.02.009","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T14:16:28Z","timestamp":1342188988000},"page":"951-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Epidemic of Iron Overload in Dialysis Population Caused by Intravenous Iron Products: A Plea for Moderation"],"prefix":"10.1016","volume":"125","author":[{"given":"Nosratola D.","family":"Vaziri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2012.02.009_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","article-title":"Oxidative stress in uremia: nature, mechanisms and potential consequences","volume":"24","author":"Vaziri","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","article-title":"Clinical aspects of iron use in the anemia of kidney disease","volume":"18","author":"H\u00f6rl","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib3","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1523-1755.2004.00580.x","article-title":"The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure","volume":"65","author":"Lim","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.02.009_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1523-1755.2001.00976.x","article-title":"Increase in plasma esterified F 2 isoprostanes following intravenous iron infusion in patients on hemodialysis","volume":"60","author":"Salahudeen","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.02.009_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/ajkd.2002.36334","article-title":"Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation","volume":"40","author":"Tovbin","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2012.02.009_bib6","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/ndt\/gfl263","article-title":"Impact of iron sucrose therapy on leukocyte surface molecules and reactive oxygen species in haemodialysis patients","volume":"21","author":"Guz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2012.02.009_bib7","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1681\/ASN.2007101084","article-title":"Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients","volume":"19","author":"Kuo","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000334939","article-title":"Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion\/infiltration","volume":"35","author":"Kamanna","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib9","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Drueke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2012.02.009_bib10","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1172\/JCI118661","article-title":"Increased ferritin gene expression in atherosclerotic lesions","volume":"97","author":"Pang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2012.02.009_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.02.009_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2369-11-16","article-title":"Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival","volume":"11","author":"Gupta","year":"2010","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/5.2.130","article-title":"Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study","volume":"5","author":"Boelaert","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2012.02.009_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08880019209016592","article-title":"Yersinia infections in patients with homozygous beta thalassemia associated with iron overload and its treatment","volume":"9","author":"Green","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib15","first-page":"377","article-title":"Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey","volume":"10","author":"Hoen","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2012.02.009_bib16","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/dc06-2625","article-title":"The role of iron in diabetes and its complications","volume":"30","author":"Swaminathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2012.02.009_bib17","first-page":"Sl6","article-title":"ll. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2012.02.009_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: A MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2012.02.009_bib20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2012.02.009_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2012.02.009_bib22","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/ndt\/gfr410","article-title":"Hepcidin: another culprit for complications in patients with chronic kidney disease?","volume":"26","author":"Nakanishi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjmed.2012.02.009_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2005-923313","article-title":"Pathophysiology of hereditary hemochromatosis","volume":"2","author":"Fleming","year":"2005","journal-title":"Semin Liver Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:58:23Z","timestamp":1757581103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934312002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002934312002227"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.02.009","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemic of Iron Overload in Dialysis Population Caused by Intravenous Iron Products: A Plea for Moderation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.01.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}